DESCRIPTION OF SETTLEMENT AGREEMENTDescription of Settlement Agreement • October 13th, 2008
Merck & Co. (“Merck”) has entered into a Settlement Agreement (“Agreement”) with certain plaintiffs’ counsel (“Negotiating Plaintiffs’ Counsel”) in order to establish a nationwide settlement program to resolve the claims of certain individuals who have suffered a heart attack, stroke, or sudden cardiac death resulting from their use of Vioxx (the “Vioxx Claimant(s)”).
DESCRIPTION OF SETTLEMENT AGREEMENT BETWEEN ALTRIADescription of Settlement Agreement • August 14th, 2023
Altria Group, Inc., Philip Morris USA, Inc., Altria Client Services LLC, Altria Enterprises LLC, and Altria Group Distribution Company (collectively “Altria”) has entered into a Settlement Agreement with court-appointed Plaintiffs’ Leadership in MDL No. 2913 and JCCP No. 5052 (together “Plaintiffs’ Leadership”1) on behalf of all Settling Government Entity Plaintiffs. The Settlement Agreement establishes a program to resolve, only as against Altria and the other Released Parties2, the actions and claims that the Settling Government Entity Plaintiffs had, now have, or will have in the future against Altria in connection with: the design, manufacture, production, advertisement, marketing, distribution, sale, use, and performance of JUUL Products; Altria’s conduct related to its investment in JUUL Labs, Inc. (“JLI”); and Altria’s interactions with JLI and JLI-related persons.
